NO982294D0 - Farmas÷ytiske blandinger omfattende flurbiprofen - Google Patents

Farmas÷ytiske blandinger omfattende flurbiprofen

Info

Publication number
NO982294D0
NO982294D0 NO982294A NO982294A NO982294D0 NO 982294 D0 NO982294 D0 NO 982294D0 NO 982294 A NO982294 A NO 982294A NO 982294 A NO982294 A NO 982294A NO 982294 D0 NO982294 D0 NO 982294D0
Authority
NO
Norway
Prior art keywords
flurbiprofen
pharmaceutical
surface mixtures
mixtures
sugar
Prior art date
Application number
NO982294A
Other languages
English (en)
Other versions
NO982294L (no
NO317287B1 (no
Inventor
David Michael Barrett
Carl Simon Smith
David Michael Thurgood
Original Assignee
Boots Co Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boots Co Plc filed Critical Boots Co Plc
Publication of NO982294D0 publication Critical patent/NO982294D0/no
Publication of NO982294L publication Critical patent/NO982294L/no
Publication of NO317287B1 publication Critical patent/NO317287B1/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/04—Drugs for disorders of the respiratory system for throat disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Physiology (AREA)
  • Nutrition Science (AREA)
  • Zoology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pulmonology (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Rheumatology (AREA)
  • Engineering & Computer Science (AREA)
  • Otolaryngology (AREA)
  • Pain & Pain Management (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Materials For Medical Uses (AREA)
NO19982294A 1995-11-22 1998-05-20 Farmasoytiske blandinger omfattende flurbiprofen NO317287B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9523833.3A GB9523833D0 (en) 1995-11-22 1995-11-22 Medical treatment
PCT/EP1996/005208 WO1997018802A1 (en) 1995-11-22 1996-11-21 Pharmaceutical compositions comprising flurbiprofen

Publications (3)

Publication Number Publication Date
NO982294D0 true NO982294D0 (no) 1998-05-20
NO982294L NO982294L (no) 1998-07-20
NO317287B1 NO317287B1 (no) 2004-10-04

Family

ID=10784245

Family Applications (1)

Application Number Title Priority Date Filing Date
NO19982294A NO317287B1 (no) 1995-11-22 1998-05-20 Farmasoytiske blandinger omfattende flurbiprofen

Country Status (21)

Country Link
US (2) US5889057A (no)
EP (1) EP0862424B1 (no)
CN (1) CN1148177C (no)
AT (1) ATE252382T1 (no)
AU (1) AU707749B2 (no)
BG (1) BG64166B1 (no)
CA (1) CA2238271C (no)
CZ (1) CZ289643B6 (no)
DE (1) DE69630460T2 (no)
DK (1) DK0862424T3 (no)
ES (1) ES2208768T3 (no)
GB (1) GB9523833D0 (no)
HU (1) HU225235B1 (no)
IL (1) IL124568A0 (no)
NO (1) NO317287B1 (no)
NZ (1) NZ322933A (no)
PT (1) PT862424E (no)
RU (1) RU2203655C2 (no)
SK (1) SK284092B6 (no)
UA (1) UA46807C2 (no)
WO (1) WO1997018802A1 (no)

Families Citing this family (40)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9523833D0 (en) * 1995-11-22 1996-01-24 Boots Co Plc Medical treatment
AU8107998A (en) * 1997-05-22 1998-12-11 Boots Company Plc, The Pharmaceutical compositions
GB9710521D0 (en) * 1997-05-22 1997-07-16 Boots Co Plc Process
WO1998052545A1 (en) * 1997-05-22 1998-11-26 The Boots Company Plc Pharmaceutical compositions of flurbiprofen and burn-masking agent for treating sore throat
EP1206283A2 (en) * 1999-05-17 2002-05-22 Aesgen, Inc. Improved cellular uptake of bioactive agents
AU2001257022B2 (en) * 2000-04-13 2005-02-03 Mayo Foundation For Medical Education And Research Abeta 42 lowering agents
EP1446118B1 (en) * 2001-11-13 2008-01-09 Pharmacia Corporation Oral dosage form of parecoxib
US20090035260A1 (en) * 2002-07-29 2009-02-05 Therapicon Srl Enhanced nasal composition of active peptide
WO2004012662A2 (en) * 2002-08-01 2004-02-12 Aesgen, Inc. Improved treatment of cancer with glutamine
WO2004071431A2 (en) * 2003-02-05 2004-08-26 Myriad Genetics, Inc. Method and composition for treating neurodegenerative disorders
US20040265359A1 (en) * 2003-04-17 2004-12-30 Sacks Gordon S. Oral delivery formulations of L-glutamine
JP2007528857A (ja) * 2003-07-11 2007-10-18 ミリアド ジェネティクス， インコーポレイテッド アルツハイマー病の処置のための薬学的方法、投与レジメンおよび投薬形態
FR2865648B1 (fr) * 2004-02-03 2006-06-30 Philippe Perovitch Procede de diffusion de molecules insolubles en milieu aqueux et composition mettant en oeuvre ce procede
ITMI20040235A1 (it) * 2004-02-13 2004-05-13 Therapicon Srl Preparazione farmaceutica per il cavo orale
WO2006001877A2 (en) * 2004-04-13 2006-01-05 Myriad Genetics, Inc. Combination treatment for neurodegenerative disorders comprising r-flurbiprofen
KR20070004036A (ko) * 2004-04-29 2007-01-05 키스톤 리테이닝 월 시스템스, 아이엔씨 벽, 옹벽 및 그 외 유사한 것을 위한 베니어
WO2006020850A2 (en) * 2004-08-11 2006-02-23 Myriad Genetics, Inc. Pharmaceutical composition and method for treating neurodegenerative disorders
WO2006020852A2 (en) * 2004-08-11 2006-02-23 Myriad Genetics, Inc. Pharmaceutical composition and method for treating neurodegenerative disorders
BRPI0514303A (pt) * 2004-08-11 2008-06-10 Myriad Genetics Inc composição farmacêutica e método para tratar distúrbios neurodegenerativos
GB2423710A (en) * 2005-03-01 2006-09-06 Boots Healthcare Int Ltd Lozenge production process
EP1909777A2 (en) * 2005-07-22 2008-04-16 Myriad Genetics, Inc. High drug load formulations and dosage forms
AU2006312119B2 (en) * 2005-11-02 2010-04-29 Teikoku Pharma Usa, Inc. Organoleptically acceptable ibuprofen oral dosage formulations, methods of making and using the same
US7282224B1 (en) * 2006-06-09 2007-10-16 Guthy-Renker Corporation Pain relief composition
WO2008006099A2 (en) * 2006-07-07 2008-01-10 Myriad Genetics, Inc. Treatment of psychiatric disorders
US7754234B2 (en) * 2006-07-12 2010-07-13 Jones Thomas L Composition and method of treating a sore throat
US20080107747A1 (en) * 2006-10-23 2008-05-08 Roederer Joy E Pain relief composition
EA200901188A1 (ru) * 2007-07-23 2010-04-30 ТЕЙКОКУ ФАРМА ЮЭсЭй, ИНК. Органолептически приемлемые дозированные лекарственные формы индольных агонистов серотониновых рецепторов для перорального применения и способы их применения
HUE052685T2 (hu) 2009-05-19 2021-05-28 Neuroderm Ltd Dopa-dekarboxiláz inhibitorok folyamatos adagolására szolgáló készítmények
IT1397132B1 (it) 2009-12-01 2013-01-04 Alfa Wassermann Spa Composizioni comprendenti antiinfiammatori non steroidei.
RS57047B1 (sr) * 2010-11-15 2018-05-31 Neuroderm Ltd Neprekidno davanje l dope, inhibitora dopa dekarboksilaze, inhibitora katehol-o-metil transferaze i kompozicije za iste
GB201021267D0 (en) * 2010-12-15 2011-01-26 Reckitt Benckiser Healthcare Int Ltd Novel pharmaceutical formulation
NZ703341A (en) 2012-06-05 2016-11-25 Neuroderm Ltd Compositions comprising apomorphine and organic acids and uses thereof
GB201216893D0 (en) 2012-09-21 2012-11-07 Aesica Pharmaceuticals Ltd Drug substance preparations, pharmaceutical compositions and dosage forms comprising s-(+)-flurbiprofen
ES2836325T3 (es) 2014-03-13 2021-06-24 Neuroderm Ltd Composiciones del inhibidor de la dopa descarboxilasa
US10258585B2 (en) 2014-03-13 2019-04-16 Neuroderm, Ltd. DOPA decarboxylase inhibitor compositions
CN110812331A (zh) * 2018-08-10 2020-02-21 北京普德康利医药科技发展有限公司 一种氟比洛芬咽部滞留颗粒
US11844754B2 (en) 2020-11-17 2023-12-19 Neuroderm, Ltd. Methods for treatment of Parkinson's disease
US11331293B1 (en) 2020-11-17 2022-05-17 Neuroderm, Ltd. Method for treatment of Parkinson's disease
US11213502B1 (en) 2020-11-17 2022-01-04 Neuroderm, Ltd. Method for treatment of parkinson's disease
CN118125916A (zh) * 2022-09-23 2024-06-04 南京知和医药科技有限公司 一种s-（+）-氟比洛芬盐及其制备方法、药物组合物和用途

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1062721A (en) * 1975-12-15 1979-09-18 Anthony A. Sinkula Propionic acid derivatives
US4389393A (en) * 1982-03-26 1983-06-21 Forest Laboratories, Inc. Sustained release therapeutic compositions based on high molecular weight hydroxypropylmethylcellulose
JPH0647532B2 (ja) * 1983-08-31 1994-06-22 ジ アツプジヨン カンパニ− 歯槽骨吸収の治療
AU6656886A (en) * 1985-12-16 1987-06-18 Cilag A.G. Pharmaceutical composition of suprofen
AU8320387A (en) * 1986-10-22 1988-05-25 Upjohn Company, The Treatment of gingivitis with ibuprofen or flurbiprofen
JPS63156715A (ja) * 1986-12-19 1988-06-29 Teisan Seiyaku Kk 即効性の徐放化製剤
JP2540581B2 (ja) * 1988-02-04 1996-10-02 三省製薬株式会社 外用剤
US4931473A (en) * 1989-02-15 1990-06-05 Richardson-Vicks Inc. Anesthetic oral compositions
US5190981A (en) * 1989-08-17 1993-03-02 Sepracor Inc. Formulation containing S(+) enantiomer of flurbiprofen or ketoprofen and method of use for oral administration for prevention and treatment of bone loss associated with periodontal disease
DK0486561T4 (da) * 1989-08-17 1999-04-26 Sepracor Inc Bukkalt præparat indeholdende S(+)-ketoprofen
JP2738092B2 (ja) * 1989-11-17 1998-04-08 ライオン株式会社 口腔用組成物
JPH0426618A (ja) * 1990-05-21 1992-01-29 Japan Tobacco Inc トローチ剤
IT1243342B (it) * 1990-07-13 1994-06-10 Farcon Ag Composizioni farmaceutiche orali liquide ad attivita' antiinfiammatoria
DE4028906A1 (de) * 1990-09-12 1992-03-19 Paz Arzneimittelentwicklung Arzneimittel sowie deren herstellung und deren verwendung bei der bekaempfung von schmerzen und/oder entzuendungen und/oder fieber an tieren und menschen
DE69230151T2 (de) * 1992-12-04 2000-03-09 Mayor Pharmaceuticals Laboratories, Inc. Sprühfähige analgetische zusammensetzung und verfahren zu irher verwendung
EP0674527A1 (en) * 1992-12-21 1995-10-04 The Procter & Gamble Company Use of s(+) antipodes of analgesic agents for the manufacture of a composition to treat respiratory disorders
US5458879A (en) * 1994-03-03 1995-10-17 The Procter & Gamble Company Oral vehicle compositions
ES2211916T3 (es) * 1994-09-02 2004-07-16 Virginia Commonwealth University Composicion para aliviar dolor, que contiene un analgesico no narcortico y un potenciador de analgesia.
US5567733B1 (en) * 1995-04-27 1999-08-24 Jon G Dishler Irritation relief using nonsteroidal anti-inflammatory compounds
JPH11508593A (ja) * 1995-07-05 1999-07-27 ザ、プロクター、エンド、ギャンブル、カンパニー 加温化合物
GB9523833D0 (en) * 1995-11-22 1996-01-24 Boots Co Plc Medical treatment
ATE288255T1 (de) * 1996-04-12 2005-02-15 Novadel Pharma Inc Polares bukkales spray
US5955098A (en) * 1996-04-12 1999-09-21 Flemington Pharmaceutical Corp. Buccal non polar spray or capsule

Also Published As

Publication number Publication date
CN1148177C (zh) 2004-05-05
PT862424E (pt) 2004-02-27
CN1207677A (zh) 1999-02-10
AU2611997A (en) 1997-06-11
ATE252382T1 (de) 2003-11-15
AU707749B2 (en) 1999-07-22
EP0862424B1 (en) 2003-10-22
GB9523833D0 (en) 1996-01-24
US5889057A (en) 1999-03-30
EP0862424A1 (en) 1998-09-09
IL124568A0 (en) 1998-12-06
ES2208768T3 (es) 2004-06-16
NO982294L (no) 1998-07-20
DE69630460T2 (de) 2004-08-19
RU2203655C2 (ru) 2003-05-10
WO1997018802A1 (en) 1997-05-29
HUP0000180A2 (hu) 2000-08-28
SK66598A3 (en) 1998-12-02
UA46807C2 (uk) 2002-06-17
CA2238271A1 (en) 1997-05-29
NZ322933A (en) 2000-02-28
SK284092B6 (sk) 2004-09-08
BG102526A (en) 1999-02-26
US6166083A (en) 2000-12-26
BG64166B1 (bg) 2004-03-31
NO317287B1 (no) 2004-10-04
DE69630460D1 (de) 2003-11-27
DK0862424T3 (da) 2003-12-29
CA2238271C (en) 2008-08-12
HUP0000180A3 (en) 2001-10-29
HU225235B1 (en) 2006-08-28
CZ289643B6 (cs) 2002-03-13
CZ156598A3 (cs) 1998-08-12

Similar Documents

Publication Publication Date Title
NO982294D0 (no) Farmas÷ytiske blandinger omfattende flurbiprofen
ATE305301T1 (de) Mittel zur hemmung von angiogenese enthaltend thalodomid und einen nsaid
ATE344226T1 (de) Aspirin-ausgelöste lipidmediatoren
ATE97570T1 (de) Arzneimittel zur verhuetung von sexuell uebertragbaren krankheiten.
DK398587D0 (da) Antitumorvirksomt laegemiddel
DK0776229T3 (da) Brusedyse
DK0458699T3 (da) Anvendelse af baclofen til fremstilling af lægemidler til behandling af angina pectoris
TR199901853T2 (xx) Gastrointestinal lipaz inhibit�r�n�n kullan�lmas�.
ITRM920869A0 (it) Medicamenti per trattare condizioni infiammatorie o per analgesia.
DE3860201D1 (de) Entzuendungshemmende agentien.
DK0624374T3 (da) Anvendelse af sulodexid og medicin, som indeholder dette, til behandlingen af diabetisk nephropati
ES2159362T3 (es) Utilizacion de la 1-(2-naft-2-iletil)-4-(3-trifluorometilfenil)-1,2,3,6-tetrahidropiridina para la preparacion de medicamentos destinados para el tratamiento de la esclerosis lateral amiotrofica.
ATE360428T1 (de) Analgetisches arzneimittel
DK0479093T3 (da) Oligosaccharidderivater og deres anvendelse som lægemidler
PT806957E (pt) Terapeutica de construcao para infeccao por hiv utilizando o inibidor de protease de hiv indinavir e o inibidor de transcriptase reversa 3tc
ES1022449Y (es) Aparato terapeutica para tratamiento de sintomas ocasionados por enfermedades.
DE68906513D1 (de) Topisch anzuwendende diclofenac enthaltende arzneizubereitungen.
ATE239739T1 (de) Phospholipid-derivate von nichtsteroiden entzündungshemmenden medikamenten
PT869785E (pt) 4-hidroxicumarina-3-carboxamidas para o tratamento de diabetes mellitus nao insulinodependente
DK89489D0 (da) Anvendelse af halogenerede allylaminer til fremstilling af et farmaceutisk praeparat
ITTO930806A1 (it) Purificazione dell' 1, 1-dicloro-1-fluoroetano.
WO1999025327A3 (en) Small molecule intervention in hiv-1 replication
DE3853551D1 (de) Plasmabehandlungsvorrichtung.
DK1237552T3 (da) Kombination af lumilysergol og riluzol for forebyggelse og/eller behandling af motorisk neuron-sygdomme
FR2689764B1 (fr) Utilisation de dérivés de peptides pour la fabrication de médicaments inhibiteurs des endopeptidases 24.15 et 24.16.

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees